Teva Pharmaceutical Industries
TEVA
#503
Rank
$50.13 B
Marketcap
$42.97
Share price
0.84%
Change (1 day)
77.12%
Change (1 year)

Teva Pharmaceutical Industries (TEVA) - P/B ratio

P/B ratio as of November 2026 : 6.46

According to Teva Pharmaceutical Industries's latest financial reports the company has a price-to-book ratio of 2.89584.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Teva Pharmaceutical Industries - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-311.4623.76%
2022-12-311.1849.93%
2021-12-310.7858-16.53%
2020-12-310.941431.42%
2019-12-310.7163-33.31%
2018-12-311.074.49%
2017-12-311.03-2.23%
2016-12-311.05-46.82%
2015-12-311.98-4.91%
2014-12-312.0839.29%
2013-12-311.497.19%
2012-12-311.39-12.68%
2011-12-311.60-24.99%
2010-12-312.13-17.67%
2009-12-312.5811.69%
2008-12-312.31-15.27%
2007-12-312.7323.77%
2006-12-312.21-52.03%
2005-12-314.6032.62%
2004-12-313.47-27.44%
2003-12-314.78-12.25%
2002-12-315.44

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Novartis
NVS
8.23 27.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.95-69.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.45-77.53%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
8.73 35.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
5.83-9.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
4.24-34.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
3.09-52.18%๐Ÿ‡ฎ๐Ÿ‡ณ India